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We isolated a hybridoma cell line which produced monoclonal antibody to one determinant of an exoantigen of Candida albicans. The immunoglobulin G antibody product was characterized by using a Western blot technique and was used for a serological analysis of numerous homologous and heterologous yeast isolates. Based on specific immunologic determinants, C. albicans strains were identified and clustered into five groups. The monoclonal antibodies were effective reagents for identifying and serotyping our C. albicans isolates; they have potential application in the epidemiology of yeast infections.
Monoclonal antibodies can be invaluable tools for studying the properties of large groups of microorganisms, including fungi. The most common use of monoclonal antibodies is in the development of immunodiagnostic tests for detecting infection by specific organisms.
Previous reports of immunoidentification of pathogenic fungi (4) and yeasts (7) performed with polyvalent antisera prompted us to evaluate the potential use of monoclonal antibodies for identification and serotyping of the pathogenic yeast Candida albicans. The question which we asked was whether monoclonal antibodies, because of their specificity, could be more useful than polyvalent antisera.
In this paper we describe the production and characterization of a monoclonal antibody to Candida albicans soluble antigen for use in the Western blot technique. Cells and media. Cell line NS1, which was kindly provided by Lenore Pereira, Virology Laboratory, Department of Health, Berkeley, Calif., was the myeloma cell line used in this study. The myeloma cell line and the hybrids derived from its fusion with BALB/c mouse spleen cells were grown in RPMI 1640 medium (GIBCO Laboratories, Grand Island, N.Y.) supplemented with 20% fetal bovine serum (lot 12103059; GIBCO).
MATERIALS AND METHODS

Cultures
Hybridization and selection of antibody-producing hybrids. The hybridization procedure, the selection of hybrids which produced the desired monoclonal antibodies, and the check of the monoclonality of the antibodies were carried out as previously described (1, 5) . The immunoglobulin class was determined by immunodiffusion with rabbit-specific antisera (Miles Laboratories, Inc., Elkhart, Ind.). ferred to nitrocellulose. A sheet of nitrocellulose paper to which peptides had been transferred was cut into strips for reaction with monoclonal antibodies. The nitrocellulose strips were incubated for 30 min at room temperature in phosphate-buffered saline (PBS) containing 5% (vol/vol) horse serum. Each nitrocellulose strip was then incubated at 37°C for 30 min in a shaker with 0.2 ml of hybridoma culture fluid diluted 1:10 in PBS containing 5% horse serum. The strips were then washed twice in PBS to remove unbound antibodies. To detect bound monoclonal antibodies, each strip was then incubated in 3 ml of PBS containing 5% horse serum for 30 min at room temperature in a' shaker. Horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulin G (Miles Laboratories) was diluted 1:500 in PBS containing 5% horse serum, and 3 ml was added to each strip for 30 min at 37°C in a shaker. After extensive washing in PBS, the strips were developed in 100 ml of water with 1 ml of a 1% solution of 4-chloro-1-naphthol (Sigma Chemical Co., St. Louis, Mo.) in methanol. Hydrogen peroxide was added to a final concentration of 0.01%. As bluish bands appeared, the strips were collected and dried. A few strips from each gel were differentially fixed and stained with 0.1% Coomassie blue for visualizing the molecular weight markers and controlling the efficiency of transfer. Plotting the migration patterns permitted accurate evaluation of the molecular weights of the antigenic determinants in the strips that reacted with the monoclonal antibodies (1).
RESULTS
Nine hybrids producing monoclonal antibodies belonging to the immunoglobulin G class were produced by fusion.
When the Candida albicans reference antigen was electrophoretically separated in denaturing gels and then immobilized on nitrocellulose strips, we did not detect any diversity in the monoclonal antibodies to yeast proteins. Candida albicans monoclonal antibody UCSC 1 was selected for its avidity properties. When the antigens of all of the yeast isolates studied were tested by the Western blot technique, Candida albicans monoclonal antibody UCSC 1 displayed a potential to discriminate among various isolates (Fig. 1) .
All of the Candida albicans strains had a species-specific determinant located at a molecular weight of 12,000. Candida albicans monoclonal antibody UCSC 1 was used to characterize five different presumptive serotypes within the species which reacted in different isolates with other antigenic determinants having different molecular weights. Cross-reactions occurred with other yeast species having different molecular weights (Table 1) . Interestingly, the antigenic determinant with the closest molecular weight was detected in the Malassezia furfur isolate.
DISCUSSION
Traditionally, identification of Candida albicans isolates has been based on biochemical and morphological criteria. More recently, serological methods have been used for classification of the Candida species and their serotypes (7). However, serological methods may prevent autoagglutination, require combined biological tests, and recognize only the two serotypes (serotypes A and B) generally accepted within the species Candida albicans (2) .
For this study, we had to make a preliminary choice (on grounds other than questionable immunization procedures) between using intact cells and using soluble antigens as immunogens. Because this study was intended to be directed to immunoidentification of opportunistic yeasts, we used a soluble antigen, namely, a reference exoantigen, since this type of antigen has previously been highly effective for the Using a monoclonal antibody to a soluble antigen of Candida albicans, we demonstrated the presence of 12,000-dalton antigenic determinant that was shared by the type strain and by all of the Candida albicans isolates tested. No yeast isolate belonging to any other species investigated had an identical antigenic determinant. The similarity in molecular weight between the 12,000-dalton antigenic determinant of Candida albicans strains and the 13,000-dalton determinant of the M. furfur isolate examined suggests that there is a common function, but does not pose any diagnostic problem; thus, monoclonal antibodies can be readily adapted for identification purposes.
Furthermore, we found that such antigenic determinants may be expressed at different molecular weights in different strains within the species, since they are located on different molecules. Based on specific immunological determinants, the Candida albicans strains were clustered in five presumptive serotypes.
Additional experiments will be needed to determine whether the antigenically related proteins having different molecular weights are modifications of a common protein or the polymerized states of a protein which was not separated under the denaturing conditions used in this study.
The data presented in this paper show that monoclonal antibodies are powerful reagents for the identification and serotyping of Candida albicans strains. They also have potential application to the epidemiology of yeast infections. We expect that the serotypes are dependent upon the number of selected monoclonal antibodies used for analysis and that additional groupings should emerge as more hybridomas are used.
The poor variability in the responses of monoclonal antibodies to the immunization antigen could be attributed to a dominant immunogenic component. In our institute, work is in progress to achieve partial purification of the exoantigen by using Candida albicans monoclonal antibody UCSC 1 as an immunoadsorbent in affinity chromatography. This procedure should permit us to obtain a purified antigen which is depleted-of the relative antigenic determinant. The use of such a purified antigen for mouse immunization should permit the production of different monoclonal antibodies.
